Skip to main navigation Skip to search Skip to main content

A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis

  • Jung Min Shin
  • , Seol Hee Kim
  • , Thavasyappan Thambi
  • , Dong Gil You
  • , Jueun Jeon
  • , Jong Oh Lee
  • , Bong Youl Chung
  • , Dong Gyu Jo
  • , Jae Hyung Park
  • Sungkyunkwan University
  • Korea Research Institute of Standards and Science
  • Humedix, Co. Ltd.

Research output: Contribution to journalArticlepeer-review

Abstract

In an effort to improve the therapeutic efficacy of methotrexate (MTX), we prepared the hyaluronic acid–MTX conjugate for targeted therapy of rheumatoid arthritis (RA). Owing to the pH-sensitive nature of the conjugate, MTX was rapidly released under the mildly acidic conditions, similar to the environment of inflamed synovial tissue in RA.

Original languageEnglish
Pages (from-to)7632-7635
Number of pages4
JournalChemical Communications
Volume50
Issue number57
DOIs
StatePublished - 19 Jun 2014

Fingerprint

Dive into the research topics of 'A hyaluronic acid–methotrexate conjugate for targeted therapy of rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this